Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Essential Oils as Antimicrobials against Acinetobacter baumannii: Experimental and Literature Data to Definite Predictive Quantitative Composition–Activity Relationship Models Using Machine Learning Algorithms JOURNAL OF CHEMICAL INFORMATION AND MODELING 2025
Using Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in obese patients. A real-life, single-center observational study ANTIBIOTICS 2025
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection. Prospective cohort study ECLINICALMEDICINE 2024
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2024
Resting - state EEG rhytms are abnormal in post covid - 19 patients with brain fog whithout cognitive and affective disorders CLINICAL NEUROPHYSIOLOGY 2024
In-label, off-label prescription, efficacy and tolerability of dalbavancin. Report from a National Registry INFECTION 2024
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose VACCINE 2024
SERUM LIPOPOLYSACCHARIDE-BINDING PROTEIN (LBP) IS ASSOCIATED WITH DIGITAL ULCERS (DUS) IN SYSTEMIC SCLEROSIS (SSC) PATIENTS JOURNAL OF SCLERODERMA AND RELATED DISORDERS 2024
The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients VACCINES 2024
Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy JOURNAL OF INFECTION AND CHEMOTHERAPY 2024
Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit BMC INFECTIOUS DISEASES 2024
Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2024
Prospects for combined analyses of hadronic emission from $$\gamma $$-ray sources in the Milky Way with CTA and KM3NeT EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2024
Could SP-A and SP-D Serum Levels Predict COVID-19 Severity? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2024
The impact of Cytomegalovirus infection on natural killer and CD8+ t cell phenotype in multiple sclerosis BIOLOGY 2024
Neutrophil Cathepsin G and Thrombosis in COVID-19 CIRCULATION RESEARCH 2024
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience FRONTIERS IN MICROBIOLOGY 2024
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. A multi-centre clinical experience INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2024
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2024

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

Laboratori di ricerca

Laboratori della Sezione di Malattie Infettive

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma